Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

CBIO holding history

Crescent Biopharma, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CBIO overviewAll 13F holders of CBIOFull Q2 2026 holdings

Shares (Q2 2026)
175,182
Value
$3.15M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of CBIO by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026175,182$3.15M<0.1%+92,476+111.8%AddedHolders
Q1 202682,706$1.52M<0.1%+75,581+1,060.8%AddedHolders
Q4 20257,125$84.5K<0.1%−5,536−43.7%ReducedHolders
Q3 202512,661$150.5K<0.1%+12,438+5,577.6%AddedHolders
Q2 2025223$3.60K<0.1%−465,690−100.0%ReducedHolders
Q1 2025465,913$97.8K<0.1%+237,045+103.6%AddedHolders
Q4 2024228,868$57.0K<0.1%+160,428+234.4%AddedHolders
Q3 202468,440$11.6K<0.1%−14,580−17.6%ReducedHolders
Q2 202483,020$23.4K<0.1%+81,520+5,434.7%AddedHolders
Q1 20241,500$4.50K<0.1%+817+119.6%AddedHolders
Q4 2023683$1.61K<0.1%+683NewHolders
Q3 20230$00.0%−6,323−100.0%Sold outHolders
Q2 20236,323$11.0K<0.1%−5,097−44.6%ReducedHolders
Q1 202311,420$14.4K<0.1%+11,420NewHolders
Q4 20220$00.0%−17,262−100.0%Sold outHolders
Q3 202217,262$10.0K<0.1%+17,262NewHolders
Q2 20220$00.0%−32−100.0%Sold outHolders
Q1 202232$00.0%−21,022−99.8%ReducedHolders
Q4 202121,054$30.0K<0.1%+21,022+65,693.8%AddedHolders
Q3 202132$00.0%−10,270−99.7%ReducedHolders
Q2 202110,302$24.0K<0.1%−17,152−62.5%ReducedHolders
Q1 202127,454$83.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.